Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 56

    1.

    Antithrombotic prophylaxis in elderly patients with atrial fibrillation.

    Hylek EM.

    Semin Thromb Hemost. 2009 Sep;35(6):548-53. Epub 2009 Sep 28.PMID: 19787558 [PubMed - in process]Related articles

    2.

    Incidence and predictors of bleeding or thrombosis following polypectomy in patients receiving and not receiving anticoagulation therapy.

    Witt DM, Delate T, McCool KH, Dowd MB, Clark NP, Crowther MA, Garcia DA, Ageno W, Dentali F, Hylek EM, Rector WG; on behalf of the WARPED Consortium§§.

    J Thromb Haemost. 2009 Aug 28. [Epub ahead of print]PMID: 19719825 [PubMed - as supplied by publisher]Related articles

    3.

    The need for new oral anticoagulants in clinical practice.

    Hylek EM.

    J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. Review.PMID: 19571764 [PubMed - indexed for MEDLINE]Related articles

    4.

    Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

    Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium.

    Blood. 2009 Jul 30;114(5):952-6. Epub 2009 May 13.PMID: 19439733 [PubMed - indexed for MEDLINE]Related articles

    5.

    Measuring quality of oral anticoagulation care: extending quality measurement to a new field.

    Rose AJ, Berlowitz DR, Frayne SM, Hylek EM.

    Jt Comm J Qual Patient Saf. 2009 Mar;35(3):146-55. Review.PMID: 19326806 [PubMed - indexed for MEDLINE]Related articles

    6.

    Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil.

    Lopes RD, Becker RC, Garcia D, Hylek EM, Granger CB, Lourenço DM, Nader HB, Maffei FH, Cesena FH, Nicolau JC, Timmerman A, Rocha AT, de Paiva EF, Guimaraes HP, Carvalho AC, D'Amico EA, Moreira-Filho CA, Aldrighi JM, Lopes AC.

    J Thromb Thrombolysis. 2009 Jul;28(1):106-16. Epub 2009 Mar 26. Review.PMID: 19322521 [PubMed - indexed for MEDLINE]Related articles

    7.

    Understanding low INR in clinical practice.

    Hylek EM, Rose AJ.

    Thromb Haemost. 2009 Mar;101(3):417-8. No abstract available. PMID: 19277399 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clopidogrel, genetics, and drug responsiveness.

    Freedman JE, Hylek EM.

    N Engl J Med. 2009 Jan 22;360(4):411-3. No abstract available. PMID: 19164193 [PubMed - indexed for MEDLINE]Related articles

    9.

    Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.

    Hylek EM, Becker RC.

    Ann Neurol. 2008 Nov;64(5):480-3. No abstract available. PMID: 19067369 [PubMed - indexed for MEDLINE]Related articles

    10.

    Warfarin dose management affects INR control.

    Rose AJ, Ozonoff A, Berlowitz DR, Henault LE, Hylek EM.

    J Thromb Haemost. 2009 Jan;7(1):94-101. Epub 2008 Oct 18.PMID: 18983486 [PubMed - indexed for MEDLINE]Related articles

    11.

    Warfarin for atrial fibrillation in community-based practise.

    Rose AJ, Ozonoff A, Henault LE, Hylek EM.

    J Thromb Haemost. 2008 Oct;6(10):1647-54.PMID: 18853483 [PubMed - indexed for MEDLINE]Related articles

    12.

    Oral anticoagulant therapy for patients with atrial fibrillation--an update.

    Hylek EM.

    Thromb Res. 2008;123 Suppl 1:S46-9. Epub 2008 Sep 21. Review. No abstract available. PMID: 18809205 [PubMed - indexed for MEDLINE]Related articles

    13.

    Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.

    Lopes RD, Piccini JP, Hylek EM, Granger CB, Alexander JH.

    J Thromb Thrombolysis. 2008 Dec;26(3):167-74. Epub 2008 Sep 21. Review.PMID: 18807225 [PubMed - indexed for MEDLINE]Related articles

    14.
    15.

    Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

    Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

    Pharmacotherapy. 2008 Aug;28(8):960-7.PMID: 18657012 [PubMed - indexed for MEDLINE]Related articles

    17.

    The representation of women on the editorial boards of major medical journals: a 35-year perspective.

    Jagsi R, Tarbell NJ, Henault LE, Chang Y, Hylek EM.

    Arch Intern Med. 2008 Mar 10;168(5):544-8. No abstract available. PMID: 18332302 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination.

    Hylek EM, Solarz DE.

    JACC Cardiovasc Interv. 2008 Feb;1(1):62-4. No abstract available. PMID: 19393146 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genetic testing for warfarin dosing? Not yet ready for prime time.

    Bussey HI, Wittkowsky AK, Hylek EM, Walker MB.

    Pharmacotherapy. 2008 Feb;28(2):141-3. No abstract available. PMID: 18225960 [PubMed - indexed for MEDLINE]Related articles

    20.

    Risk of thromboembolism with short-term interruption of warfarin therapy.

    Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM.

    Arch Intern Med. 2008 Jan 14;168(1):63-9.PMID: 18195197 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.

    Hylek EM, Magnani JW.

    Europace. 2008 Jan;10(1):3-5. Epub 2007 Nov 26. No abstract available. PMID: 18039690 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Death and disability from warfarin-associated intracranial and extracranial hemorrhages.

    Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE.

    Am J Med. 2007 Aug;120(8):700-5. Epub 2007 May 24.PMID: 17679129 [PubMed - indexed for MEDLINE]Related articles

    23.

    The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.

    Evans-Molina C, Regan S, Henault LE, Hylek EM, Schwartz GR.

    J Am Geriatr Soc. 2007 Jul;55(7):1038-43.PMID: 17608876 [PubMed - indexed for MEDLINE]Related articles

    24.

    Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

    Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S.

    Circulation. 2007 May 29;115(21):2689-96. Epub 2007 May 21.PMID: 17515465 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Effectiveness of warfarin among patients with cancer.

    Rose AJ, Sharman JP, Ozonoff A, Henault LE, Hylek EM.

    J Gen Intern Med. 2007 Jul;22(7):997-1002. Epub 2007 May 3.PMID: 17476542 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?

    Hylek EM.

    Nat Clin Pract Cardiovasc Med. 2007 Apr;4(4):186-7. Epub 2007 Feb 6. No abstract available. PMID: 17290231 [PubMed]Related articles

    27.

    Response to Letter by Testa et al.

    Hylek EM, Henault LE, Evans-Molina C, Shea C, Regan S.

    Stroke. 2006 Oct 19. [Epub ahead of print] No abstract available. PMID: 17053186 [PubMed - as supplied by publisher]Related articles

    28.

    Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.

    Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE.

    J Am Geriatr Soc. 2006 Aug;54(8):1231-6.PMID: 16913990 [PubMed - indexed for MEDLINE]Related articles

    29.

    The "gender gap" in authorship of academic medical literature--a 35-year perspective.

    Jagsi R, Guancial EA, Worobey CC, Henault LE, Chang Y, Starr R, Tarbell NJ, Hylek EM.

    N Engl J Med. 2006 Jul 20;355(3):281-7.PMID: 16855268 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.

    Hylek EM, D'Antonio J, Evans-Molina C, Shea C, Henault LE, Regan S.

    Stroke. 2006 Apr;37(4):1075-80. Epub 2006 Mar 9.PMID: 16527999 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    The risk of hemorrhage among patients with warfarin-associated coagulopathy.

    Garcia DA, Regan S, Crowther M, Hylek EM.

    J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. Epub 2006 Jan 26.PMID: 16487849 [PubMed - indexed for MEDLINE]Related articles

    32.

    Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

    Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H.

    Chest. 2006 Jan;129(1):174-81. Review.PMID: 16424429 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Antithrombotic therapy in atrial fibrillation.

    Garcia DA, Hylek EM.

    Clin Geriatr Med. 2006 Feb;22(1):155-66, x. Review.PMID: 16377472 [PubMed - indexed for MEDLINE]Related articles

    34.

    Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

    Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS.

    Circulation. 2005 Sep 20;112(12):1687-91. Epub 2005 Sep 12.PMID: 16157766 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.

    Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM.

    Chest. 2005 Jun;127(6):2049-56.PMID: 15947319 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

    Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

    Ann Intern Med. 2004 Nov 16;141(10):745-52.PMID: 15545674 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Paracetamol (acetaminophen) and warfarin interaction: unraveling the pivotal role of the vitamin K cycle.

    Hylek EM.

    Thromb Haemost. 2004 Oct;92(4):672-3. No abstract available. PMID: 15467892 [PubMed - indexed for MEDLINE]Related articles

    38.

    Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.

    Hylek EM.

    Semin Vasc Med. 2003 Aug;3(3):271-8. Review.PMID: 15199460 [PubMed - indexed for MEDLINE]Related articles

    40.

    Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

    JAMA. 2003 Nov 26;290(20):2685-92.PMID: 14645310 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

    Go AS, Reed GL, Hylek EM, Phillips KA, Liu L, Henault LE, Selby JV, Singer DE.

    J Thromb Thrombolysis. 2003 Feb;15(1):41-6.PMID: 14574075 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.

    N Engl J Med. 2003 Sep 11;349(11):1019-26.PMID: 12968085 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.

    Hylek EM, Regan S, Henault LE, Gardner M, Chan AT, Singer DE, Barry MJ.

    Arch Intern Med. 2003 Mar 10;163(5):621-7.PMID: 12622610 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.

    Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM.

    Neurology. 2002 Jul 23;59(2):193-7.PMID: 12136056 [PubMed - indexed for MEDLINE]Related articles

    45.

    Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

    Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ.

    Ann Intern Med. 2001 Sep 18;135(6):393-400.PMID: 11560452 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.
    47.

    Oral anticoagulants. Pharmacologic issues for use in the elderly.

    Hylek EM.

    Clin Geriatr Med. 2001 Feb;17(1):1-13. Review.PMID: 11270124 [PubMed - indexed for MEDLINE]Related articles

    48.

    Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

    Rosand J, Hylek EM, O'Donnell HC, Greenberg SM.

    Neurology. 2000 Oct 10;55(7):947-51.PMID: 11061249 [PubMed - indexed for MEDLINE]Related articles

    49.

    Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

    Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE.

    Circulation. 2000 Jul 4;102(1):11-3.PMID: 10880408 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

    Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

    Arch Intern Med. 2000 Jun 12;160(11):1612-7.PMID: 10847254 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...